• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝损伤后的再生:机制、细胞间相互作用和治疗创新。

Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations.

机构信息

Translational Medicine Centre, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.

Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.

出版信息

Clin Transl Med. 2024 Aug;14(8):e1812. doi: 10.1002/ctm2.1812.

DOI:10.1002/ctm2.1812
PMID:39152680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11329751/
Abstract

The liver possesses a distinctive capacity for regeneration within the human body. Under normal circumstances, liver cells replicate themselves to maintain liver function. Compensatory replication of healthy hepatocytes is sufficient for the regeneration after acute liver injuries. In the late stage of chronic liver damage, a large number of hepatocytes die and hepatocyte replication is blocked. Liver regeneration has more complex mechanisms, such as the transdifferentiation between cell types or hepatic progenitor cells mediated. Dysregulation of liver regeneration causes severe chronic liver disease. Gaining a more comprehensive understanding of liver regeneration mechanisms would facilitate the advancement of efficient therapeutic approaches. This review provides an overview of the signalling pathways linked to different aspects of liver regeneration in various liver diseases. Moreover, new knowledge on cellular interactions during the regenerative process is also presented. Finally, this paper explores the potential applications of new technologies, such as nanotechnology, stem cell transplantation and organoids, in liver regeneration after injury, offering fresh perspectives on treating liver disease.

摘要

肝脏在人体中具有独特的再生能力。在正常情况下,肝细胞会自我复制以维持肝脏功能。健康肝细胞的代偿性复制足以在急性肝损伤后进行再生。在慢性肝损伤的晚期,大量肝细胞死亡且肝细胞复制受阻。肝脏再生具有更复杂的机制,例如细胞类型之间的转分化或肝祖细胞介导的转分化。肝脏再生的失调会导致严重的慢性肝病。更全面地了解肝脏再生机制将有助于推进有效的治疗方法。本综述概述了与各种肝脏疾病中肝脏再生不同方面相关的信号通路。此外,还介绍了在再生过程中细胞相互作用的新知识。最后,本文探讨了新技术(如纳米技术、干细胞移植和类器官)在损伤后肝脏再生中的潜在应用,为治疗肝脏疾病提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe6/11329751/cd160f0dd394/CTM2-14-e1812-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe6/11329751/0c6b6651010e/CTM2-14-e1812-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe6/11329751/4a36e8b4d691/CTM2-14-e1812-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe6/11329751/af39288b92d7/CTM2-14-e1812-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe6/11329751/9eac7938f860/CTM2-14-e1812-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe6/11329751/cd160f0dd394/CTM2-14-e1812-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe6/11329751/0c6b6651010e/CTM2-14-e1812-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe6/11329751/4a36e8b4d691/CTM2-14-e1812-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe6/11329751/af39288b92d7/CTM2-14-e1812-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe6/11329751/9eac7938f860/CTM2-14-e1812-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe6/11329751/cd160f0dd394/CTM2-14-e1812-g005.jpg

相似文献

1
Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations.肝损伤后的再生:机制、细胞间相互作用和治疗创新。
Clin Transl Med. 2024 Aug;14(8):e1812. doi: 10.1002/ctm2.1812.
2
Liver regeneration: biological and pathological mechanisms and implications.肝脏再生:生物学和病理学机制及其意义。
Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):40-55. doi: 10.1038/s41575-020-0342-4. Epub 2020 Aug 6.
3
Liver regeneration: Cellular origin and molecular mechanisms.肝脏再生:细胞起源与分子机制。
Liver Int. 2022 Jul;42(7):1486-1495. doi: 10.1111/liv.15174. Epub 2022 Feb 24.
4
CXC chemokine signaling in the liver: impact on repair and regeneration.CXC 趋化因子信号在肝脏中的作用:对修复和再生的影响。
Hepatology. 2011 Oct;54(4):1445-53. doi: 10.1002/hep.24457. Epub 2011 Jun 29.
5
Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion.肝脏再生中的祖细胞:控制其激活和增殖的分子反应
APMIS. 2005 Nov-Dec;113(11-12):876-902. doi: 10.1111/j.1600-0463.2005.apm_386.x.
6
Revisiting the liver: from development to regeneration - what we ought to know!再探肝脏:从发育到再生——我们应该了解的!
Int J Dev Biol. 2018;62(6-7-8):441-451. doi: 10.1387/ijdb.170264JL.
7
Hepatic stem and progenitor cells in liver diseases and hepatocarcinogenesis.肝脏疾病与肝癌发生中的肝干细胞和祖细胞
Minerva Gastroenterol Dietol. 2009 Jun;55(2):111-21.
8
The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases.间充质干细胞在参与治疗肝脏疾病中的多种功能作用。
J Cell Mol Med. 2015 Mar;19(3):511-20. doi: 10.1111/jcmm.12482. Epub 2014 Dec 23.
9
Expansion and Hepatic Differentiation of Adult Blood-Derived CD34+ Progenitor Cells and Promotion of Liver Regeneration After Acute Injury.成年血液来源的CD34+祖细胞的扩增与肝分化以及急性损伤后肝脏再生的促进
Stem Cells Transl Med. 2016 Jun;5(6):723-32. doi: 10.5966/sctm.2015-0268. Epub 2016 Apr 13.
10
Liver regeneration.肝脏再生
Hepatology. 2006 Feb;43(2 Suppl 1):S45-53. doi: 10.1002/hep.20969.

引用本文的文献

1
Therapeutic potential of plant-derived natural products against drug-induced liver injury.植物源天然产物抗药物性肝损伤的治疗潜力
Front Pharmacol. 2025 Sep 1;16:1652860. doi: 10.3389/fphar.2025.1652860. eCollection 2025.
2
DLGAP5 Promotes Acute Liver Injury via Hepatocyte Pyroptosis-Driven Macrophage Metabolic Reprogramming and M1 Polarization.DLGAP5通过肝细胞焦亡驱动的巨噬细胞代谢重编程和M1极化促进急性肝损伤。
Int J Biol Sci. 2025 Aug 30;21(12):5563-5585. doi: 10.7150/ijbs.118024. eCollection 2025.
3
Investigating the shared genetic information between serum concentration levels of liver enzymes and cholelithiasis.

本文引用的文献

1
Acquisition of epithelial plasticity in human chronic liver disease.在人类慢性肝脏疾病中获得上皮可塑性。
Nature. 2024 Jun;630(8015):166-173. doi: 10.1038/s41586-024-07465-2. Epub 2024 May 22.
2
Multimodal decoding of human liver regeneration.多模态解码人类肝脏再生。
Nature. 2024 Jun;630(8015):158-165. doi: 10.1038/s41586-024-07376-2. Epub 2024 May 1.
3
First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure.首个 MKK4 抑制剂增强肝脏再生并预防肝功能衰竭。
研究肝酶血清浓度水平与胆石症之间的共享遗传信息。
BMC Gastroenterol. 2025 Aug 7;25(1):564. doi: 10.1186/s12876-025-04162-w.
4
Liver regeneration after partial hepatectomy: Triggers and mechanisms.部分肝切除术后的肝脏再生:触发因素与机制
World J Hepatol. 2025 Jul 27;17(7):107378. doi: 10.4254/wjh.v17.i7.107378.
5
New insights into liver injury and regeneration from single-cell transcriptomics.单细胞转录组学在肝脏损伤与再生方面的新见解
eGastroenterology. 2025 Jul 23;3(3):e100202. doi: 10.1136/egastro-2025-100202. eCollection 2025.
6
Exosomes From Intestinal Epithelial Cells Promote Hepatic Differentiation of Liver Progenitor Cells in Gut-Liver-on-a-Chip Models.肠道上皮细胞来源的外泌体在肠-肝芯片模型中促进肝祖细胞的肝向分化。
Adv Sci (Weinh). 2025 Aug;12(32):e17478. doi: 10.1002/advs.202417478. Epub 2025 Jul 6.
7
Developments and Applications of Liver-on-a-Chip Technology-Current Status and Future Prospects.芯片肝技术的发展与应用——现状与未来展望
Biomedicines. 2025 May 22;13(6):1272. doi: 10.3390/biomedicines13061272.
8
Triggering Mechanisms of Hepatocyte Repopulation during Liver Regeneration.肝脏再生过程中肝细胞再填充的触发机制
Biomol Ther (Seoul). 2025 Jul 1;33(4):582-593. doi: 10.4062/biomolther.2025.035. Epub 2025 Jun 12.
9
Influencing factors and mechanism of hepatocyte regeneration.肝细胞再生的影响因素及机制
J Transl Med. 2025 Apr 30;23(1):493. doi: 10.1186/s12967-025-06278-9.
10
Role of mitogens in normal and pathological liver regeneration.有丝分裂原在正常及病理性肝再生中的作用。
Hepatol Commun. 2025 Apr 30;9(5). doi: 10.1097/HC9.0000000000000692. eCollection 2025 May 1.
Cell. 2024 Mar 28;187(7):1666-1684.e26. doi: 10.1016/j.cell.2024.02.023. Epub 2024 Mar 14.
4
Preclinical efficacy and safety of encapsulated proliferating human hepatocyte organoids in treating liver failure.包裹增殖人肝细胞类器官治疗肝衰竭的临床前疗效和安全性。
Cell Stem Cell. 2024 Apr 4;31(4):484-498.e5. doi: 10.1016/j.stem.2024.02.005. Epub 2024 Mar 7.
5
Mesenchymal Stem Cell-Derived Exosomes in Various Chronic Liver Diseases: Hype or Hope?间充质干细胞来源的外泌体在各种慢性肝病中的应用:炒作还是希望?
J Inflamm Res. 2024 Jan 10;17:171-189. doi: 10.2147/JIR.S439974. eCollection 2024.
6
Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development.基于干细胞的策略:生物人工肝发展的未来方向。
Stem Cell Rev Rep. 2024 Apr;20(3):601-616. doi: 10.1007/s12015-023-10672-5. Epub 2024 Jan 3.
7
Unveiling the power of microenvironment in liver regeneration: an in-depth overview.揭示微环境在肝脏再生中的作用:深入概述。
Front Genet. 2023 Dec 13;14:1332190. doi: 10.3389/fgene.2023.1332190. eCollection 2023.
8
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis.血管内皮生长因子A信使核糖核酸脂质纳米颗粒在急慢性肝病中促进胆管上皮细胞向肝细胞转化,并逆转脂肪变性和肝纤维化。
Cell Stem Cell. 2023 Dec 7;30(12):1640-1657.e8. doi: 10.1016/j.stem.2023.10.008. Epub 2023 Nov 28.
9
Balance of Gata3 and Ramp2 in hepatocytes regulates hepatic vascular reconstitution in postoperative liver regeneration.肝细胞中 Gata3 和 Ramp2 的平衡调节肝再生术后肝血管重建。
J Hepatol. 2024 Feb;80(2):309-321. doi: 10.1016/j.jhep.2023.10.016. Epub 2023 Oct 31.
10
NOTCH signalling - a core regulator of bile duct disease?NOTCH 信号通路——胆管疾病的核心调控因子?
Dis Model Mech. 2023 Sep 1;16(9). doi: 10.1242/dmm.050231. Epub 2023 Aug 22.